Nano-X Imaging (NNOX) held its Q4 2024 earnings call on March 31, 2025, featuring CEO Erez Meltzer and CFO Ran Daniel. The company reported significant regulatory achievements, including FDA general use clearance in December and CE Mark designation for Nanox.ARC in February 2025. Meltzer highlighted advancements in market deployment, positive customer feedback, new channel partnerships, and efforts to penetrate the European market, along with updates on their Nanox.AI team and ongoing clinical trials to support their innovative imaging technology.
